Sabra Healthcare REIT, Inc. (SBRA)

10.5 0.29%
May 28 close; Powered by Koyfin
Pros
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward P/B ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
High short share of float
High short interest

Pros

  1. SBRA profitability is improving. The YoY profit margin change was 10.76 percentage points. See SBRA profitability chart.
  2. SBRA forward dividend yield is 10.62%, higher than the industry (3.48%) and sector (1.12%) forward dividend yields. See SBRA forward dividend chart.
  3. SBRA forward P/E ratio is 17.01, which is low compared to its industry peers’ P/E ratios. See SBRA forward P/E ratio chart.
  4. SBRA Price/Book ratio is 0.86, which is low compared to its industry peers’ P/B ratios. See SBRA forward Price/Book ratio chart.
  5. SBRA PEG ratio (P/E adjusted for growth) is 3.44, which is low compared to its industry peers’ PEG ratios. See SBRA PEG chart.
  6. SBRA average analyst rating is Buy. See SBRA analyst rating chart.
  7. SBRA average analyst price target ($16.16) is above its current price ($11.36). See SBRA price target chart.

Cons

  1. SBRA short share of float is 7.92%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See SBRA short share of float chart.
  2. SBRA short interest (days to cover the shorts) ratio is 5.38. The stock garners more short interest than the average industry, sector or S&P 500 stock. See SBRA short interest ratio chart.